Bowel Dysfunction Related to Spina Bifida: Keep It Simple

Charlène Brochard1, Benoît Peyronnet, Anne Dariel

  • 11 Service des Maladies de l'Appareil Digestif, Centre Hospitalier Universitaire Pontchaillou, Université de Rennes 1, Rennes, France 2 Service d'Explorations Fonctionnelles Digestives, Centre Hospitalier Universitaire Pontchaillou, Université de Rennes 1, Rennes, France 3 Institut National de la Santé et de la Recherche Médicale U1235, Université de Nantes, Nantes, France 4 Centre d'Investigation Clinique 1414, Inflammation and Physiology, Université de Rennes 1, Rennes, France 5 Service d'Urologie, Centre Hospitalier Universitaire Pontchaillou, Rennes, France 6 Centre Référence National Maladies Rares Spina Bifida, Centre Hospitalier Universitaire Pontchaillou, Rennes, France 7 Institut National de la Santé et de la Recherche Médicale U991, Université de Rennes, Rennes, France.

Insights

Adults with spina bifida experience high rates of fecal incontinence and bowel dysfunction. Obesity and urologic issues, not neurological factors, are linked to these conditions.

Area of Science:

  • Urology
  • Gastroenterology
  • Neurology

Background:

  • Care for urological issues in spina bifida is established, but standardized bowel dysfunction management is lacking.
  • Bowel dysfunction is a significant concern for adults with spina bifida.

Purpose of the Study:

  • To assess bowel dysfunction and identify risk factors in adults with spina bifida.
  • Utilize validated instruments to evaluate bowel dysfunction prevalence and associated risks.

Main Methods:

  • Prospective data collection by a multidisciplinary team focusing on anorectal and urological symptoms.
  • Assessment of 228 adults with spina bifida at a French referral center.
  • Multivariate analysis to identify factors associated with severe fecal incontinence and bowel dysfunction.

Main Results:

  • High prevalence rates: 60% for severe fecal incontinence and 42% for severe bowel dysfunction.
  • Bowel dysfunction is the second most common patient concern after lower urinary tract dysfunction.
  • Independent risk factors for severe fecal incontinence include male sex, obesity, urinary incontinence, and constipation score ≥10. Soft stools were associated with less severe dysfunction. Neurologic features were not associated.

Conclusions:

  • High prevalence of severe fecal incontinence and bowel dysfunction in adults with spina bifida.
  • Obesity, urologic disorders, and stool consistency are associated with bowel dysfunction and fecal incontinence, rather than neurologic features.
  • Potential selection bias due to recruitment from a national referral center and missing data noted.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
829
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.4K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.3K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
943